MPO and inflammatory bowel disease: Administration of BSB after IBD induction significantly (p < 0.01, p < 0.001, n = 6) decreased MPO levels from 61,739.57 ± 16,904.11 (no BSB) to 17,037.41 ± 4731.17 ng/mg of protein and from 32,552.37 ± 7002.41 (no BSB) to 577.62 ± 81.21 ng/mg of protein on days 2 and 4 of IBD, respectively.